{"a":[{"_":"Apnimed dreams of IPO to fund launch of sleep apnea pill on FDA's desk","$":{"href":"/biotech/apnimed-dreams-ipo-fund-launch-sleep-apnea-pill-awaiting-fda-approval-decision","hreflang":"en"}}]}

Summary

Apnimed is planning an IPO to fund the commercial launch of an obstructive sleep apnea therapy currently awaiting FDA approval. The drug's regulatory decision is pending but no specific FDA decision date is provided in the article.